Stay updated on Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial page.

Latest updates to the Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial page
- ChecktodayChange DetectedThe page now shows Revision: v3.6.5, replacing the previous v3.6.4. This reflects a software or interface update rather than changes to the study data or record content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study history now shows a new revision entry, v3.6.4, replacing the previous v3.6.3.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new Revision: v3.6.3 entry was added to the history and the prior Revision: v3.6.2 entry was removed, reflecting a small update to the page's revision metadata.SummaryDifference0.1%

- Check43 days agoChange DetectedThe study history now includes a new revision entry, v3.6.2, and no longer lists v3.6.0, updating the page’s revision log. This reflects an administrative update to the page’s version history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe record history adds a note that no participants are being recruited anymore and updates the site revision to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.3%

- Check65 days agoChange DetectedThe record history gained a new revision entry (v3.5.5) and removed the previous revision (v3.5.4), reflecting an update to the study record timeline.SummaryDifference0.1%

Stay in the know with updates to Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Weekly vs Twice-weekly Carfilzomib in Myeloma Clinical Trial page.